Gadolinium enhancement of atherosclerotic plaque in the intracranial artery
Yue Lu,Meng-fan Ye,Jie-ji Zhao,Shan-shan Diao,Tan Li,Dong-xue Ding,Lu-lu Zhang,Fei-rong Yao,Yan Kong,Zhuan Xu
DOI: https://doi.org/10.1080/01616412.2021.1949682
2021-07-06
Neurological Research
Abstract:<span><b>Background</b>: Gadolinium enhancement on high resolution magnetic resonance imaging (HR-MRI) has been considered a sign of instability and inflammation of intracranial atherosclerotic plaques. Our research objective was to explore the relationship between the extent of plaque enhancement (PE), the degree of intracranial artery stenosis, and acute ischemic stroke events.<b>Methods:</b> HR-MRI was performed in 91 patients with intracranial vascular stenosis to determine the existence and intensity of PE.<b>Results:</b> Among 91 patients enrolled in the trial, there were 43 patients in the acute/subacute group (≤1 month from ischemic stroke event), 15 patients in the chronic group (>1 month from ischemic stroke event), and 33 patients in the non-culprit plaques group (no ischemic stroke event). A total of 105 intracranial atherosclerotic plaques were detected in 91 patients. 14 (13.3%) were mild-stenosis plaques, 22 (21.0%) were moderate-stenosis plaques, and 69 (65.7%) were severe-stenosis plaques. There were 12 (11.4%), 18 (17.1%), and 75 (71.4%) plaques in the non-enhanced plaque group, the mild-enhancement group, and the significant-enhancement group, respectively. The degree of PE among the acute/subacute group, the chronic group, and the non-culprit plaque group had a significant difference (P = 0.005). Enhanced plaques were more often observed in culprit plaques (acute/subacute group and chronic group) than non-culprit plaques (96.7% vs 77.3%). Non-enhanced plaques were more often observed in non-culprit plaques than culprit plaques (acute/subacute group and chronic group) (22.7% vs 3.3%). And 36.6% of the enhanced plaques were non-culprit plaques. After performing univariate and multivariate logistic regression analysis, the results showed that strong plaque enhancement (P = 0.025, odds ratio [OR] 3.700, 95% confidence interval [95% CI] 1.182–11.583) and severe stenosis (P = 0.008, OR 4.393, 95%CI 1.481–13.030) were significantly associated with acute ischemic events.<b>Conclusion:</b> Enhanced plaques were more often observed in culprit plaques, and non-enhanced plaques were more often observed in non-culprit plaques. Moreover, significant plaque enhancement and severe ICAS were closely associated with acute ischemic events.</span>
neurosciences,clinical neurology